EP1144448A2 - Adn codant les proteines tiam-2 et procede d'utilisation dudit adn - Google Patents

Adn codant les proteines tiam-2 et procede d'utilisation dudit adn

Info

Publication number
EP1144448A2
EP1144448A2 EP00902369A EP00902369A EP1144448A2 EP 1144448 A2 EP1144448 A2 EP 1144448A2 EP 00902369 A EP00902369 A EP 00902369A EP 00902369 A EP00902369 A EP 00902369A EP 1144448 A2 EP1144448 A2 EP 1144448A2
Authority
EP
European Patent Office
Prior art keywords
seq
amino acids
tiam2
polynucleotide
aal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00902369A
Other languages
German (de)
English (en)
Other versions
EP1144448A3 (fr
Inventor
David Duhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of EP1144448A2 publication Critical patent/EP1144448A2/fr
Publication of EP1144448A3 publication Critical patent/EP1144448A3/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

La présente invention concerne des séquences nucléotidiques codant les protéines TIAM-2. L'invention comprend également les dosages diagnostiques, les vecteurs d'expression, les molécules antisens, les ribozymes, et les cellules hôtes utilisées pour exprimer le polypeptide codé par la séquence nucléotidique. La présente invention comprend également les revendications concernant la séquence polypeptidique codée par les séquences nucléotidiques.
EP00902369A 1999-01-06 2000-01-06 Adn codant les proteines tiam-2 et procede d'utilisation dudit adn Withdrawn EP1144448A3 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22727899A 1999-01-06 1999-01-06
US227278 1999-01-06
PCT/US2000/000459 WO2000040607A2 (fr) 1999-01-06 2000-01-06 Adn codant les proteines tiam-2 et procede d'utilisation dudit adn

Publications (2)

Publication Number Publication Date
EP1144448A2 true EP1144448A2 (fr) 2001-10-17
EP1144448A3 EP1144448A3 (fr) 2002-03-06

Family

ID=22852486

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00902369A Withdrawn EP1144448A3 (fr) 1999-01-06 2000-01-06 Adn codant les proteines tiam-2 et procede d'utilisation dudit adn

Country Status (4)

Country Link
EP (1) EP1144448A3 (fr)
JP (3) JP4707235B2 (fr)
AU (1) AU2409700A (fr)
WO (1) WO2000040607A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020165145A1 (en) * 2000-09-25 2002-11-07 Meyers Rachel E. 33521, a novel human guanine nucleotide exchange family member and uses thereof
EP1752040A1 (fr) * 2005-08-12 2007-02-14 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Identification de distorteurs du complex-t et leurs applications
US8679760B2 (en) * 2011-05-03 2014-03-25 National Cheng Kung University Biomarker and method for evaluating risk of proliferation, invasion, or metastasis of cancer
JP6675287B2 (ja) 2016-08-23 2020-04-01 日機装株式会社 流体殺菌装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE438717T1 (de) * 1996-06-05 2009-08-15 Novartis Vaccines & Diagnostic Dp-75 kodierende dna und verfahren zu ihrer verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0040607A3 *

Also Published As

Publication number Publication date
JP2010233574A (ja) 2010-10-21
JP4707235B2 (ja) 2011-06-22
WO2000040607A3 (fr) 2001-11-01
EP1144448A3 (fr) 2002-03-06
WO2000040607A2 (fr) 2000-07-13
AU2409700A (en) 2000-07-24
JP2011083295A (ja) 2011-04-28
JP2002538774A (ja) 2002-11-19

Similar Documents

Publication Publication Date Title
JP2007289186A (ja) Dp75をコードするdnaおよびその使用のための工程
WO1996026215A1 (fr) Proteine ingap impliquee dans la neogenese des ilots pancreatiques
US20130102542A1 (en) Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
US7329741B2 (en) Polynucleotides that hybridize to DP-75 and their use
USRE39062E1 (en) INGAP protein involved in pancreatic islet neogenesis
JP2011083295A (ja) Tiam2(t細胞のリンパ腫の侵襲および転移2)ヌクレオチド交換因子
US5905146A (en) DNA binding protein S1-3
JPH10201482A (ja) カルシトニン遺伝子関連ペプチド受容体成分因子(houdc44)
JP2002300891A (ja) 新規化合物
KR19990007806A (ko) 전환 성장 인자 α HII
JP2004041175A (ja) ヒトlig−1相同体(hlig−1)
US7041497B2 (en) Nuclear factor κB inducing factor
JP4280878B2 (ja) Masl1遺伝子
US20030113869A1 (en) Human FGF gene and gene expression products
US7309783B2 (en) Mammalian early developmental regulator gene
AU708499C (en) Ingap protein involved in pancreatic islet neogenesis
US20030049699A1 (en) Polypeptide (MBP1) capable of interacting with oncogenic mutants of the P53 protein
WO2001029179A2 (fr) Regulation de l'expression genetique par des neuromodulateurs
US20030157103A1 (en) Human amine transporter antibodies
WO2003091390A2 (fr) Regulation de l'expression genique par des neuromodulateurs et identification d'une nouvelle proteine induite par le ngf denommee pincher
JP2001145493A (ja) 熱ショック蛋白質hsp47と相互作用する蛋白質
JPH11103866A (ja) 新規化合物
JPH11507813A (ja) ヒトアミン受容体
JP2003038174A (ja) ヒトアミン受容体

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010713

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

XX Miscellaneous

Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR.

PUAK Availability of information related to the publication of the international search report

Free format text: ORIGINAL CODE: 0009015

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 12N 15/63 B

Ipc: 7C 07K 14/47 A

Ipc: 7G 01N 33/53 B

Ipc: 7C 07K 16/18 B

Ipc: 7C 12N 15/11 B

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130416